Efficacy and safety of different immunosuppressive therapies in patients with membranous nephropathy and high PLA2R antibody titer
L Deng, Q Huang, J Wang, K Luo, J Liu… - Frontiers in …, 2022 - frontiersin.org
Background: This study aimed to evaluate clinical features and prognosis and therapy
option of patients with different risk ranks based on antibody against the M-type …
option of patients with different risk ranks based on antibody against the M-type …
Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: the optimal cut-off value for Chinese patients
Y Liu, X Li, C Ma, P Wang, J Liu, H Su, H Zhuo… - Clinica Chimica …, 2018 - Elsevier
Background The M-type phospholipase A2 receptor (PLA2R) is a specific target autoantigen
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …
A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy
S Kalantari, M Nafar - Biomarkers in Medicine, 2017 - Taylor & Francis
Membranous nephropathy (MN) is relatively major cause of nephrotic syndrome in adults
which is recognized as an organ-specific autoimmune disease. The etiology of most cases is …
which is recognized as an organ-specific autoimmune disease. The etiology of most cases is …
Ultrasensitive quantitation of anti-phospholipase A2 receptor antibody as a diagnostic and prognostic indicator of idiopathic membranous nephropathy
Q Zhang, B Huang, X Liu, B Liu, Y Zhang, Z Zhang… - Scientific Reports, 2017 - nature.com
Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful for affirming the diagnosis of
idiopathic membranous nephropathy (IMN). Time-resolved fluoroimmunoassay (TRFIA) is …
idiopathic membranous nephropathy (IMN). Time-resolved fluoroimmunoassay (TRFIA) is …
Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy
L Liu, B Chang, X Wu, Y Guo, Y Pan… - Vascular Health and Risk …, 2018 - Taylor & Francis
Objectives The aims of this study were to detect the expression of M phospholipase A2
receptor (PLA2R) in the kidney tissue of patients with idiopathic membranous nephropathy …
receptor (PLA2R) in the kidney tissue of patients with idiopathic membranous nephropathy …
Мембранозная нефропатия в российской популяции
ВА Добронравов, ДА Майер, ОВ Бережная… - Терапевтический …, 2017 - cyberleninka.ru
Резюме Цель исследования. Анализ клинико-морфологических проявлений и оценка
эффективности терапии мембранозной нефропатии (МН). Материалы и методы …
эффективности терапии мембранозной нефропатии (МН). Материалы и методы …
[PDF][PDF] Anti-phospholipase A2 receptor antibodies: Current applications in primary membranous nephropathy
M Relvas, R Batata, AT Nunes… - Port J Nephrol Hypert, 2020 - cdn02.spnefro.pt
Membranous nephropathy (MN) is the denomination of a specific glomerular disease
induced by the deposition of immune complexes at the glomerular basement membrane …
induced by the deposition of immune complexes at the glomerular basement membrane …
The Role of Anti-Phospholipase A2 Receptor Autoantibody as a Biomarker of Idiopathic Membranous Nephropathy
RMB Batata - PQDT-Global, 2019 - search.proquest.com
Background: Membranous nephropathy (MN) is an important cause of nephrotic syndrome
in adults. The M-type phospholipase A2 receptor (PLA2R) present in the podocyte, has been …
in adults. The M-type phospholipase A2 receptor (PLA2R) present in the podocyte, has been …